“…Phenotypic ESBL-screening and susceptibility testing was performed on all (approximately 800 isolates/year) Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates collected during 2001-and spring 2007 at the Department of Clinical Microbiology, University Hospital Linköping, Sweden with agar disk diffusion according to the Swedish Reference Group for Antibiotics (http://www.srga.org) as described previously (Monstein et al, 2007;Tärnberg et al, 2009). In brief, Cefadroxil was used for the screening of cephalosporin resistance, which was followed up by testing of resistant isolates with cefotaxime and ceftazidime or direct testing with cefotaxime and ceftazidime with disk diffusion and Etest (bioMerieux Sverige AB, Askim, Sweden).…”